Difficulty: Medium
Average Score: 90%
Practice
A 47-year-old woman presents to the emergency department complaining of blurry vision, vomiting, and excessive sweating after splashing herself with carbamate insecticide while gardening. Her condition improves after administration of atropine. Which of the following is true of competitive antagonists?
Correct answer
C
Rationale
In this scenario, the correct answer is C) For enzymes \( K_m \) is unchanged.
Competitive antagonists, like atropine in this case, compete with the natural ligand for binding to the receptor site. In the context of enzymes, competitive antagonists bind to the active site of the enzyme, thereby preventing the substrate from binding. However, these antagonists do not affect the maximum velocity of the enzyme-catalyzed reaction, nor do they alter the \( K_m \) value. \( K_m \) is a constant that represents the substrate concentration at which an enzyme works at half of its maximum velocity. In the presence of a competitive antagonist, the enzyme can still reach its maximum velocity; hence, \( K_m \) remains unchanged.
Regarding the incorrect options:
A) Competitive antagonists do not decrease the efficacy of proteins they bind to; they only compete for binding without affecting the intrinsic activity.
B) Competitive antagonists do not decrease the potency of proteins they bind to; potency refers to the drug concentration required to produce a specific effect, which is not altered by competitive antagonists.
D) Competitive antagonists can be overcome by increasing the concentration of the protein's native ligand or substrate because they compete for binding reversibly.
Understanding the mechanism of competitive antagonists is crucial in pharmacology to predict and manage drug interactions and their effects on enzyme kinetics. This knowledge aids in prescribing appropriate therapies and understanding the underlying principles of drug action.
Competitive antagonists, like atropine in this case, compete with the natural ligand for binding to the receptor site. In the context of enzymes, competitive antagonists bind to the active site of the enzyme, thereby preventing the substrate from binding. However, these antagonists do not affect the maximum velocity of the enzyme-catalyzed reaction, nor do they alter the \( K_m \) value. \( K_m \) is a constant that represents the substrate concentration at which an enzyme works at half of its maximum velocity. In the presence of a competitive antagonist, the enzyme can still reach its maximum velocity; hence, \( K_m \) remains unchanged.
Regarding the incorrect options:
A) Competitive antagonists do not decrease the efficacy of proteins they bind to; they only compete for binding without affecting the intrinsic activity.
B) Competitive antagonists do not decrease the potency of proteins they bind to; potency refers to the drug concentration required to produce a specific effect, which is not altered by competitive antagonists.
D) Competitive antagonists can be overcome by increasing the concentration of the protein's native ligand or substrate because they compete for binding reversibly.
Understanding the mechanism of competitive antagonists is crucial in pharmacology to predict and manage drug interactions and their effects on enzyme kinetics. This knowledge aids in prescribing appropriate therapies and understanding the underlying principles of drug action.